- Government Procurement
Subject Matter Details
Government Contract Pursued
- Abbott Diagnostics Canada and Canadian healthcare technology company Avricore Health Inc have presented a platform utilizing Abbott’s ID NowTM molecular testing device and Avricore’s HealthTabTM to test patients for COVID-19 and utilize the software’s ability to directly report results from the device automatically.
Avricore is seeking a contract for the provision of licensing to fully activate the rapid detection, and track and trace technologies offered by the HealthTabTM test.
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Health Canada (HC)
Prime Minister's Office (PMO)
Public Safety Canada (PS)
Public Services and Procurement Canada (PSPC)
Transport Canada (TC)
No government funding was received during the last completed financial year.
Client Contact Information
303-750 W Pender St
Vancouver, BC V6C 2T7
Hector Bremner, CEO
Parent Company Information
Avricore Health / Avricore Health is not a subsidiary of any other parent companies.
Coalition Members Information
Avricore Health / Avricore Health is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Avricore Health / Avricore Health are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
- Health Tab Inc. / Health Tab Inc.
2300-1177 West Hastings St.
Vancouver, BC V6E 2K3
Public offices held
50 O'Connor Street
Ottawa,, ON K1P 6L2
Consultant Firm and Address
Diplomat Consulting / Diplomat Consulting
9128 83 Avenue
Edmonton, AB T6C 1B7